Search for: "PFIZER" Results 4441 - 4460 of 4,566
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
1 Feb 2008, 12:00 am
: (IPBiz),State of the Union address 28 Jan 2008: statement regarding patenting human life: (IPBiz), (Patently-O),Alnylam Pharmaceuticals secures UK patent covering molecules that affect RNA interference: (SmartBrief),Doha style compulsory licences for exports: The politics…: (Spicy IP),Pushing to compulsory licensing: Pharma companies heading closer to Doha: (Spicy IP),Financial Express on the battle between big pharma companies and the generic… [read post]
5 Jun 2013, 5:29 am by Schachtman
Sander Greenland and others have raised various theoretical objections to the argument that relative risks should exceed two before attribution can be made in specific cases. [read post]
25 Apr 2015, 11:03 am by Schachtman
The first edition of the Reference Manual on Scientific Evidence [Manual] was published in 1994, a year after the Supreme Court delivered its opinion in Daubert. [read post]
2 Mar 2022, 2:33 pm
 The one mercy of President Biden's 2022 State of the Union Address was that there was no surprises. [read post]
1 Mar 2010, 7:11 pm
Blistex, Ciba, Pfizer, 3M, Edgecraft, Darex, Cisco, Bunn-O-Matic, Oreck, Novartis, Merck, etc. [read post]
12 Nov 2017, 11:00 pm by Kevin LaCroix
A recurring issue in securities cases involves the question of when plaintiffs may rely on the presumption of reliance under the fraud on the market doctrine. [read post]
31 Dec 2020, 9:03 pm by Joshua Burd
In lieu of our regular Friday feature—the Week in Review—The Regulatory Review is recapping some of the top regulatory news from the past year, including the coronavirus pandemic, the 2020 presidential election, and more. [read post]
16 Aug 2011, 11:53 am by Jason Neufeld
Pfizer, ConocoPhilips, Lockeed Martin, Dow Chemical, etc… are on their board of directors). [read post]
16 Jun 2015, 7:22 am by Schachtman
In Daubert, the Supreme Court came to the realization that expert witness opinion testimony was allowed under the governing statute, Federal Rule of Evidence 702, only when that witness’s “scientific, technical, or other specialized knowledge” would help the fact finder. [read post]
25 Jun 2009, 4:29 am
This post is largely about drug and medical device litigation "inside baseball. [read post]
13 Jun 2013, 7:05 pm by Mary Dwyer
At its June 13, 2013 Conference, the Court will consider petitions seeking review of issues such as the constitutionality of the president’s recess appointments to the National Labor Relations Board, the constitutionality of a state law requiring pre-abortion ultrasounds, whether habeas proceedings can be used to challenge sex offender registration, common law immunity for foreign officials acting on behalf of foreign states, and whether equitable tolling is available under the Hague… [read post]
5 Dec 2021, 4:26 pm by Eugene Volokh
" The one vaccine approved for use in 16-year-olds is the Pfizer-BioNTech vaccine. [read post]
26 Feb 2024, 12:17 pm by Michael Lowe
First things first, it’s important to understand exactly what is involved in the Medicaid program here in Texas. [read post]
15 Mar 2007, 2:12 am by Dariusz Czuchaj
Other pharmaceutical companies that have filed WIPO cases in the past include Pharmacia & Upjohn (in relation to Rogaine), American Home Products, McNeil Consumer Brands (Tylenol), Pfizer (Viagra), Merck, Sanofi-Aventis (Ambien), CVS Pharmacy, Lilly ICOS, Valeant, and Bayer. [read post]